Literature DB >> 15468527

A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28.

Takafumi Tsuboi1, Osamu Kaneko, Ya-Ming Cao, Mayumi Tachibana, Yakushijin Yoshihiro, Takayoshi Nagao, Hiroji Kanbara, Motomi Torii.   

Abstract

The antigenic diversity observed in many vaccine candidates is one of the difficulties to design effective malaria vaccine. Since it is prerequisite to survey genetic polymorphism of the vaccine candidate antigens for the vaccine development, it is necessary to establish efficient screening method to detect the genetic polymorphism from a large number of samples. Here, we have established efficient polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) method to detect nucleotide diversity of the malaria transmission-blocking vaccine candidates Pvs25 and Pvs28. We can distinguish all 4 haplotypes of Pvs25 by this method. By introducing BsmI-digestion step for Pvs28, we can distinguish 15/16 haplotypes by single electrophoresis. Since this method requires neither sequencing nor radioisotope labeling, it will be easy to transfer the method into a field based high throughput screening of genetic polymorphism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15468527     DOI: 10.1016/j.parint.2004.01.012

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  7 in total

1.  Genetic Variation of MSP-1 Gene in Plasmodium vivax Isolated from Patients in Hormozgan Province, Iran using SSCP-PCR.

Authors:  A Miahipour; H Keshavarz; A Heidari; A Raeisi; M Rezaeian; S Rezaie
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

2.  Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.

Authors:  Takeshi Arakawa; Mayumi Tachibana; Takeshi Miyata; Tetsuya Harakuni; Hideyasu Kohama; Yasunobu Matsumoto; Naotoshi Tsuji; Hajime Hisaeda; Anthony Stowers; Motomi Torii; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

3.  Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent.

Authors:  Surendra K Prajapati; Hema Joshi; Virendra K Dua
Journal:  Malar J       Date:  2011-05-02       Impact factor: 2.979

4.  Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China.

Authors:  Hui Feng; Li Zheng; Xiaotong Zhu; Gege Wang; Yanyan Pan; Ying Li; Yimei Yang; Yahui Lin; Liwang Cui; Yaming Cao
Journal:  Parasit Vectors       Date:  2011-11-28       Impact factor: 3.876

5.  Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates.

Authors:  Jung-Mi Kang; Hye-Lim Ju; Sung-Ung Moon; Pyo-Yun Cho; Young-Yil Bahk; Woon-Mok Sohn; Yun-Kyu Park; Seok Ho Cha; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2013-04-30       Impact factor: 2.979

6.  Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive Selection.

Authors:  Ricardo A Chaurio; M Andreína Pacheco; Omar E Cornejo; Ester Durrego; Craig E Stanley; Andreína I Castillo; Sócrates Herrera; Ananias A Escalante
Journal:  PLoS Negl Trop Dis       Date:  2016-06-27

7.  Exploration of genetic diversity of Plasmodium vivax circumsporozoite protein (Pvcsp) and Plasmodium vivax sexual stage antigen (Pvs25) among North Indian isolates.

Authors:  Hargobinder Kaur; Rakesh Sehgal; Archit Kumar; Alka Sehgal; Praveen K Bharti; Devendra Bansal; Pradyumna K Mohapatra; Jagadish Mahanta; Ali A Sultan
Journal:  Malar J       Date:  2019-09-06       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.